Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2010, Article ID 820876, 6 pages
http://dx.doi.org/10.1155/2010/820876
Research Article

Effect of Glucose or Fat Challenge on Aspirin Resistance in Diabetes

1Division of Endocrinology, Department of Medicine, Arizona Health Sciences Center, University of Arizona, 1656 E Mabel Street, Tucson, AZ 85724, USA
2Cardiovascular and Thoracic Surgery and the Sarver Heart Center, Arizona Health Sciences Center, University of Arizona, Tucson, AZ 85724, USA
3Southern Arizona VA Health Care System, Tucson, AZ 85723, USA

Received 29 July 2010; Accepted 1 December 2010

Academic Editor: Dariush Elahi

Copyright © 2010 Hussein N. Yassine et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. DiChiara, K. P. Bliden, U. S. Tantry et al., “The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study,” Diabetes, vol. 56, no. 12, pp. 3014–3019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Watala, “Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus,” Current Pharmaceutical Design, vol. 11, no. 18, pp. 2331–2365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. T. H. Wang, D. L. Bhatt, and E. J. Topol, “Aspirin and clopidogrel resistance: an emerging clinical entity,” European Heart Journal, vol. 27, no. 6, pp. 647–654, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Lordkipanidzé, C. Pharand, D. A. Palisaitis, and J. G. Diodati, “Aspirin resistance: truth or dare,” Pharmacology and Therapeutics, vol. 112, no. 3, pp. 733–743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. W. H. Chen, XI. Cheng, P. Y. Lee et al., “Aspirin resistance and adverse clinical events in patients with coronary artery disease,” American Journal of Medicine, vol. 120, no. 7, pp. 631–635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. W. H. Chen, P. Y. Lee, W. Ng, H. F. Tse, and C. P. Lau, “Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment,” Journal of the American College of Cardiology, vol. 43, no. 6, pp. 1122–1126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. W. Eikelboom, J. Hirsh, J. I. Weitz, M. Johnston, Q. Yi, and S. Yusuf, “Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events,” Circulation, vol. 105, no. 14, pp. 1650–1655, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Le Guyader, G. Pacheco, N. Seaver, G. Davis-Gorman, J. Copeland, and P. F. McDonagh, “Inhibition of platelet GPIIb-IIIa and P-selectin expression by aspirin is impaired by stress hyperglycemia,” Journal of Diabetes and Its Complications, vol. 23, no. 1, pp. 65–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Watala, J. Golanski, J. Pluta et al., “Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control,” Thrombosis Research, vol. 113, no. 2, pp. 101–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. H. H. M. V. Oostrom, T. J. Rabelink, C. Verseyden et al., “Activation of leukocytes by postprandial lipemia in healthy volunteers,” Atherosclerosis, vol. 177, no. 1, pp. 175–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Davì, M. T. Guagnano, G. Ciabattoni et al., “Platelet activation in obese women: role of inflammation and oxidant stress,” Journal of the American Medical Association, vol. 288, no. 16, pp. 2008–2014, 2002. View at Google Scholar · View at Scopus
  12. H. A. Tran, S. S. Anand, G. J. Hankey, and J. W. Eikelboom, “Aspirin resistance,” Thrombosis Research, vol. 120, no. 3, pp. 337–346, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. R. A. Kloner, “The "merry christmas coronary" and "happy new year heart attack" phenomenon,” Circulation, vol. 110, no. 25, pp. 3744–3745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. T. M. Kolettis, A. Papathanasiou, D. Tziallas, H. J. Milionis, C. K. Kastanioti, and K. Achenbach, “Afternoon nap, meal ingestion and circadian variation of acute myocardial infarction,” International Journal of Cardiology, vol. 123, no. 3, pp. 338–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lordkipanidzé, C. Pharand, E. Schampaert, J. Turgeon, D. A. Palisaitis, and J. G. Diodati, “A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease,” European Heart Journal, vol. 28, no. 14, pp. 1702–1708, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Tschoepe, P. Roesen, J. Esser et al., “Large platelets circulate in an activated state in diabetes mellitus,” Seminars in Thrombosis and Hemostasis, vol. 17, no. 4, pp. 433–438, 1991. View at Google Scholar · View at Scopus
  17. P. D. Winocour, “Platelet turnover in advanced diabetes,” European Journal of Clinical Investigation, vol. 24, Supplement 1, pp. 34–37, 1994. View at Google Scholar · View at Scopus
  18. M. Friend, I. Vucenik, and M. Miller, “Platelet responsiveness to aspirin in patients with hyperlipidaemia,” British Medical Journal, vol. 326, no. 7380, pp. 82–83, 2003. View at Google Scholar · View at Scopus
  19. E. A. Podrez, T. V. Byzova, M. Febbraio et al., “Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype,” Nature Medicine, vol. 13, no. 9, pp. 1086–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Davi, P. Alessandrini, A. Mezzetti et al., “In vivo formation of 8-epi-prostaglandin F(2α) is increased in hypercholesterolemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 3230–3235, 1997. View at Google Scholar · View at Scopus
  21. M. Labiós, M. Martínez, F. Gabriel, V. Guiral, E. Martínez, and J. Aznar, “Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cymetry,” Thrombosis Research, vol. 115, no. 4, pp. 263–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Keaney and J. Loscalzo, “Diabetes, oxidative stress, and platelet activation,” Circulation, vol. 99, no. 2, pp. 189–191, 1999. View at Google Scholar · View at Scopus